Accusign Doa 3/DOA 3 (Bzo/Bar/Pcp), Bzo/Bar/Pcp, Biosign Doa 3/BZO/BAR/PCP, Biosign Bzo/Bar/Pcp

FDA 510(k) K961325 · Princeton BioMeditech Corp.

Substantially Equivalent

510(k) numberK961325

Submission

Device name
Accusign Doa 3/DOA 3 (Bzo/Bar/Pcp), Bzo/Bar/Pcp, Biosign Doa 3/BZO/BAR/PCP, Biosign Bzo/Bar/Pcp
Applicant
Princeton BioMeditech Corp.
Monmouth Junction, NJ, US
Received
April 8, 1996
Decision date
June 12, 1996
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) statement available from FDA

Official FDA 510(k) record

Device classification

Product code
JXM – Enzyme Immunoassay, Benzodiazepine
Device class
Class II (moderate risk)
Regulation
21 CFR 862.3170
Specialty
Clinical Toxicology

Other 510(k)s with product code JXM

510(k)DeviceApplicantDecision
K243498Alinity c Benzodiazepines Reagent KitJXM · Special Microgenics Corporation12/11/2024SE
K221765ONLINE DAT Benzodiazepines IIJXM · Traditional Roche Diagnostics12/23/2022SE
K190968CEDIA Benzodiazepine AssayJXM · Traditional Microgenics Corporation12/09/2019SE
K173963DRI Benzodiazepine AssayJXM · Traditional Microgenics Corporation02/21/2018SE
K163590Psychemedics Microplate EIA for Benzodiazepines in HairJXM · Traditional Psychemedics Corporation09/15/2017SE
K163704Healgen Multi-Drug Urine Test Cup; Healgen Multi-Drug Urine Test Dip CardJXM · Special Healgen Scientific,, LLC08/02/2017SE
K153597Healgen Multi-Drug Urine Test Cup, Healgen Multi-Drug Urine Test Dip CardJXM · Special Healgen Scientific,, LLC05/23/2016SE
K151771Immunalysis Benzodiazepines Urine Enzyme Immunoassay, Immunalysis Multi-Drug CalibratorsJXM · Traditional Immunalysis Corporation01/05/2016SE
K151642Heagen Multi-Drug Urine Test Cup, Healgen Multi-Drug Urine Test Dip CardJXM · Special Healgen Scientific,, LLC08/13/2015SE
K150356Healgen Multi-Drug Urine Test Cup, Healgen Multi-Drug Urine Test Dip CardJXM · Special Healgen Scientific,, LLC05/13/2015SE

More from Healgen Scientific,, LLC

510(k)DeviceDecision
K251538Status™ COVID-19/Flu A&BSCA · Dual Track 11/14/2025SE
K182157BioSign Flu A+BPSZ · Special 09/18/2018SE
K130650Status DS OxyDJG · Traditional 02/26/2014SE
K133474Biosign Flu a + B, Status Flu a & BPSZ · Special 12/10/2013SE
K132465Biosign Flu a + B, Status Flu a & BPSZ · Special 09/09/2013SE
K083746Biosign Flu A+BPSZ · Traditional 11/10/2010SE
K100817Biosign Ifobtest, Biosign Fecal Occult Blood TestKHE · Traditional 07/01/2010SE
K100341Spermcheck FertilityPOV · Traditional 05/04/2010SE
K082661Biostrep a, Biosign Strep a, Statusfirst Strep aGTY · Special 10/06/2008SE
K073039Spermcheck VasectomyPOV · Traditional 01/24/2008SE

Questions and answers

When was Accusign Doa 3/DOA 3 (Bzo/Bar/Pcp), Bzo/Bar/Pcp, Biosign Doa 3/BZO/BAR/PCP, Biosign Bzo/Bar/Pcp cleared by the FDA?

Accusign Doa 3/DOA 3 (Bzo/Bar/Pcp), Bzo/Bar/Pcp, Biosign Doa 3/BZO/BAR/PCP, Biosign Bzo/Bar/Pcp (K961325) received a 510(k) decision of Substantially Equivalent on June 12, 1996, 65 days after the submission was received.

What is the product code of K961325?

The FDA product code is JXM – Enzyme Immunoassay, Benzodiazepine, a Class II (moderate risk) device regulated under 21 CFR 862.3170.